Literature DB >> 11074124

Molecular cloning and expression of human parainfluenza virus type 1 L gene.

T Takimoto1, T Bousse, A Portner.   

Abstract

The large (L) protein, a subunit of paramyxovirus RNA polymerase complex is responsible for the majority of enzymic activities involved in viral replication and transcription. To gain insight of the functions of the L protein, we cloned the L gene of human parainfluenza virus type 1 (hPIV1) and sequenced the entire gene. The L gene, which was 6800 nucleotides, encoded a protein of 2223 residues with a calculated molecular weight of 253657. The predicted amino acid sequence was highly homologous with that of Sendai virus (SV) L (86% identity). The hPIV1 L protein expressed from the cloned L gene bound hPIV1 P expressed in the same cells. When cells were transfected with hPIV1 L, P and NP genes together with SV minigenome RNA containing a chloramphenicol acetyltransferase (CAT) gene (Send-CAT), RNA was transcribed, and CAT proteins were detected. These results indicate that the protein encoded by the cloned hPIV1 L gene was biologically functional and that the hPIV1 polymerase complex recognized SV transcription initiation and termination sequences to produce viral transcripts.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11074124     DOI: 10.1016/s0168-1702(00)00207-0

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  8 in total

1.  Critical role of Rab11a-mediated recycling endosomes in the assembly of type I parainfluenza viruses.

Authors:  Raychel Stone; Tsuyoshi Hayashi; Shringkhala Bajimaya; Erin Hodges; Toru Takimoto
Journal:  Virology       Date:  2015-10-17       Impact factor: 3.616

2.  Independent structural domains in paramyxovirus polymerase protein.

Authors:  Melanie Dochow; Stefanie A Krumm; James E Crowe; Martin L Moore; Richard K Plemper
Journal:  J Biol Chem       Date:  2012-01-03       Impact factor: 5.157

3.  Sequence analysis of the Washington/1964 strain of human parainfluenza virus type 1 (HPIV1) and recovery and characterization of wild-type recombinant HPIV1 produced by reverse genetics.

Authors:  Jason T Newman; Sonja R Surman; Jeffrey M Riggs; Chris T Hansen; Peter L Collins; Brian R Murphy; Mario H Skiadopoulos
Journal:  Virus Genes       Date:  2002       Impact factor: 2.332

4.  Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV.

Authors:  Toru Takimoto; Julia L Hurwitz; Chris Coleclough; Cecilia Prouser; Sateesh Krishnamurthy; Xiaoyan Zhan; Kelli Boyd; Ruth A Scroggs; Brita Brown; Yoshiyuki Nagai; Allen Portner; Karen S Slobod
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

5.  The long noncoding region of the human parainfluenza virus type 1 f gene contributes to the read-through transcription at the m-f gene junction.

Authors:  Tatiana Bousse; Tatyana Matrosovich; Allen Portner; Atsushi Kato; Yoshiyuki Nagai; Toru Takimoto
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

6.  Host specificity of the anti-interferon and anti-apoptosis activities of parainfluenza virus P/C gene products.

Authors:  Raychel Chambers; Toru Takimoto
Journal:  J Gen Virol       Date:  2009-05-07       Impact factor: 3.891

7.  Distinct Chronic Post-Viral Lung Diseases upon Infection with Influenza or Parainfluenza Viruses Differentially Impact Superinfection Outcome.

Authors:  Geyon L Garcia; Alex Valenzuela; Tomaz Manzoni; Andrew E Vaughan; Carolina B López
Journal:  Am J Pathol       Date:  2019-12-19       Impact factor: 4.307

8.  First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens.

Authors:  Julien Nyombayire; Omu Anzala; Brian Gazzard; Etienne Karita; Philip Bergin; Peter Hayes; Jakub Kopycinski; Gloria Omosa-Manyonyi; Akil Jackson; Jean Bizimana; Bashir Farah; Eddy Sayeed; Christopher L Parks; Makoto Inoue; Takashi Hironaka; Hiroto Hara; Tsugumine Shu; Tetsuro Matano; Len Dally; Burc Barin; Harriet Park; Jill Gilmour; Angela Lombardo; Jean-Louis Excler; Patricia Fast; Dagna S Laufer; Josephine H Cox
Journal:  J Infect Dis       Date:  2016-10-17       Impact factor: 5.226

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.